Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Family Physician
M.B.B.S, M.C.P.S (Medicine)
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Internal Medicine Specialist
MBBS, FCPS, RMP
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
General Physician
M.B.B.S, MRCGP (UK)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures